Table 2.
Genotype | Control n = 176 (%) |
Hp (+) NAG n = 108 (%) |
Hp (+) Mild AG n = 52 (%) |
Hp (+) Severe AG n = 61 (%) |
Hp (−) DU n = 7 (%) |
Hp (+) DU n = 168 (%) |
Hp (−) GC n = 76 (%) |
Hp (+) GC n = 207 (%) |
|
---|---|---|---|---|---|---|---|---|---|
MBL2 codon 54 | G/G (wild type) | 103 (58.52) | 65 (60.19) | 29 (55.77) | 32 (52.46) | 4 (57.14) | 95 (56.55) | 41 (53.95) | 129 (62.32) |
G/A(heterozygote) | 63 (35.80) | 37 (34.26) | 22 (43.31) | 27 (44.26) | 3 (42.86) | 69 (41.07) | 29 (32.37) | 67 (32.37) | |
A/A (mutant) | 10 (5.68) | 6 (5.56) | 1 (1.92) | 2 (3.28) | 0 (0.00) | 4 (2.38) | 6 (5.31) | 11 (5.31) | |
G/A + A/A (A carrier) | 73 (41.48) | 43 (39.81) | 23 (44.23) | 29 (47.54) | 4 (57.14) | 73 (43.45) | 35 (46.05) | 78 (37.68) | |
IL-8 -251 | T/T (wild type) | 70 (39.77) | 52 (48.15) | 20 (38.46) | 15 (24.59) | 3 (42.86) | 81 (48.21) | 23 (30.26) | 58 (28.02) |
T/A (heterozygote) | 89 (50.57) | 49 (45.37) | 27 (51.92) | 37 (60.66) | 3 (42.86) | 73 (43.45) | 46 (60.53) | 122 (58.94) | |
A/A (mutant) | 17 (9.66) | 7 (6,48) | 5 (9.62) | 9 (16.75) | 1 (14.29) | 14 (8.33) | 7 (9.21) | 27 (13.04) | |
T/A + A/A (A carrier) | 106 (60.23) | 56 (51.85) | 32 (61.54) | 46 (75.41) | 4 (57.14) | 87 (51.79) | 53 (69.74) | 149 (71.99) |
The frequencies of MBL2 codon 54 and IL-8 -251 genotypes were not significantly different between the control and disease groups